Publications by authors named "Gerald Miletello"

Claim this Profile
A
A randomized trial of a multimodal lifestyle intervention in cancer survivors.
Justin C Brown, Phillip Nauta, Darryl Whitehead, Benjamin R Dubin, Ryan Nash, Gerald P Miletello

Front Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term progression-free survival of patients with metastatic melanoma or renal cell carcinoma following high-dose interleukin-2.
Joseph I Clark, Brendan Curti, Elizabeth J Davis, Howard Kaufman, Asim Amin, Gerald P Miletello

J Investig Med· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapy with high-dose Interleukin-2 (HD IL-2) in metastatic melanoma and renal cell carcinoma following PD1 or PDL1 inhibition.
Elizabeth I Buchbinder, Janice P Dutcher, Gregory A Daniels, Brendan D Curti, Sapna P Patel, Gerald P Miletello

J Immunother Cancer· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bendamustine, bortezomib and rituximab produces durable complete remissions in patients with previously untreated, low grade lymphoma.
Ian W Flinn, Dana S Thompson, Ralph V Boccia, Gerald Miletello, Andrew Lipman

Br J Haematol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Sequencing Targeted Therapies With High-dose Interleukin-2 Immunotherapy: An Analysis of Outcome and Survival of Patients With Metastatic Renal Cell Carcinoma From an On-going Observational IL-2 Clinical Trial: PROCLAIM.
Joseph I Clark, Michael K K Wong, Howard L Kaufman, Gregory A Daniels, Michael A Morse, Gerald Miletello

Clin Genitourin Cancer· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contemporary experience with high-dose interleukin-2 therapy and impact on survival in patients with metastatic melanoma and metastatic renal cell carcinoma.
Ajjai Alva, Gregory A Daniels, Michael K K Wong, Howard L Kaufman, Michael A Morse, Gerald Miletello

Cancer Immunol Immunother· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis